1
|
Serna C, Parrish A, Patel M, Srinivasan K, Malinauskas R, Lu Q, Jamiolkowski M. Development of a large diameter in vitro flow loop thrombogenicity test system. Artif Organs 2024. [PMID: 39221585 DOI: 10.1111/aor.14852] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2024] [Revised: 07/16/2024] [Accepted: 08/15/2024] [Indexed: 09/04/2024]
Abstract
BACKGROUND To accommodate a wider range of medical device sizes, a larger in vitro flow loop thrombogenicity test system using 9.5 -mm inner diameter (ID) tubing was developed and evaluated based on our previously established 6.4 -mm ID tubing system. METHODS Four cardiopulmonary bypass roller pumps were used concurrently to drive four flow loops during testing. To ensure that each pump produced a consistent thrombogenic response for the same material under the same test conditions, a novel dynamic roller occlusion setting method was applied. Five materials with varying thrombogenic potentials were tested: polytetrafluoroethylene (PTFE), silicone, 3D-printed nylon, latex, and nitrile rubber (BUNA). Day-old bovine blood was heparinized to a donor-specific concentration and recirculated through the flow loops containing test materials at 20 rpm for 1 h at room temperature. Material thrombogenicity was characterized by measuring the thrombus surface coverage, thrombus weight, and platelet (PLT) count reduction. RESULTS The larger tubing system can differentiate thrombogenic materials (latex, BUNA) from the thromboresistant PTFE material. Additionally, silicone and the 3D-printed nylon exhibited an intermediate thrombogenic response with significantly less thrombus surface coverage and PLT count reduction than latex and BUNA but more thrombus surface coverage than PTFE (p < 0.05). CONCLUSION The 9.5 -mm ID test system can effectively differentiate materials of varying thrombogenic potentials when appropriate pump occlusion settings and donor-specific anticoagulation are used. This system is being assessed in an interlaboratory study to develop standardized best practices for performing in vitro dynamic thrombogenicity testing of medical devices and materials.
Collapse
Affiliation(s)
- Carlos Serna
- Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA
| | - Anna Parrish
- Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA
| | - Mehulkumar Patel
- Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA
| | - Keerthana Srinivasan
- Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA
| | - Richard Malinauskas
- Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA
| | - Qijin Lu
- Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA
| | - Megan Jamiolkowski
- Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, USA
| |
Collapse
|
2
|
Ucak K, Karatas F, Cetinkaya E, Pekkan K. Synchronous PIV measurements of a self-powered blood turbine and pump couple for right ventricle support. Sci Rep 2024; 14:19962. [PMID: 39198487 PMCID: PMC11358467 DOI: 10.1038/s41598-024-70243-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2024] [Accepted: 08/14/2024] [Indexed: 09/01/2024] Open
Abstract
A blood turbine-pump system (iATVA), resembling a turbocharger was proposed as a mechanical right-heart assist device without external drive power. In this study, the iATVA system is investigated with particular emphasis on the blood turbine flow dynamics. A time-resolved 2D particle image velocimetry (PIV) set-up equipped with a beam splitter and two high speed cameras, allowed simultaneous recordings from both the turbine and pump impellers at 7 different phased-locked instances. The iATVA prototype is 3D printed using an optically clear resin following our earlier PIV protocols. Results showed that magnetically coupled impellers operated synchronously. As the turbine flow rate increased from 1.6 to 2.4 LPM, the rotational speed and relative inlet flow angle increase from 630 to 900 rpm, and 38 to 55% respectively. At the trailing edges, backflow region spanned 3/5 of the total passage outlet flow, and an extra leakage flow was observed at the leading edge. For this early turbine design, approximately, 75% of the turbine blade passage was not contributing to the impulse operation mode. The maximum non-wall shear rate was ~ 2288 s-1 near to the inlet exit, which is significantly lower than the commercial blood pumps, encouraging further research and blood experiments of this novel concept. Experimental results will improve the hydrodynamic design of the turbine impeller and volute regions and will be useful in computational fluid dynamics validation studies of similar passive devices.
Collapse
Affiliation(s)
- Kagan Ucak
- Mechanical Engineering Department, Koç University, Rumeli Feneri Kampüsü, Sarıyer, Istanbul, 34450, Turkey
| | - Faruk Karatas
- Mechanical Engineering Department, Koç University, Rumeli Feneri Kampüsü, Sarıyer, Istanbul, 34450, Turkey
| | - Emre Cetinkaya
- Mechanical Engineering, Yildiz Technical University, Istanbul, Turkey
| | - Kerem Pekkan
- Mechanical Engineering Department, Koç University, Rumeli Feneri Kampüsü, Sarıyer, Istanbul, 34450, Turkey.
| |
Collapse
|
3
|
Hayes MM, Fallon BP, Barbaro RP, Manusko N, Bartlett RH, Toomasian JM. Membrane Lung and Blood Pump Use During Prolonged Extracorporeal Membrane Oxygenation: Trends From 2002 to 2017. ASAIO J 2021; 67:1062-1070. [PMID: 33528156 PMCID: PMC8316490 DOI: 10.1097/mat.0000000000001368] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022] Open
Abstract
Extracorporeal life support (ECLS) has grown in its application since its first clinical description in the 1970s. The technology has been used to support a wide variety of mechanical support modalities and diseases, including respiratory failure, cardiorespiratory failure, and cardiac failure. Over many decades and safety and efficacy studies, followed by randomized clinical trials and thousands of clinical uses, ECLS is considered as an accepted treatment option for severe pulmonary and selected cardiovascular failure. Extracorporeal life support involves the use of support artificial organs, including a membrane lung and blood pump. Over time, changes in the technology and the management of ECLS support devices have evolved. This manuscript describes the use of membrane lungs and blood pumps used during ECLS support from 2002 to 2017 in over 65,000 patients reported to the Extracorporeal Life Support Organization Registry. Device longevity and complications associated with membrane lungs and blood pump are described and stratified by age group: neonates, pediatrics, and adults.
Collapse
Affiliation(s)
- McKenzie M. Hayes
- Extracorporeal Life Support Laboratory, Department of Surgery. University of Michigan, Ann Arbor, MI
| | - Brian P. Fallon
- Extracorporeal Life Support Laboratory, Department of Surgery. University of Michigan, Ann Arbor, MI
| | - Ryan P. Barbaro
- Department of Pediatrics, Division of Critical Care. University of Michigan, Ann Arbor, MI
- Registry Committee, Extracorporeal Life Support Organization, Ann Arbor, MI
| | - Niki Manusko
- Section of General Surgery, Department of Surgery. University of Michigan, Ann Arbor, MI
| | - Robert H. Bartlett
- Extracorporeal Life Support Laboratory, Department of Surgery. University of Michigan, Ann Arbor, MI
| | - John M. Toomasian
- Extracorporeal Life Support Laboratory, Department of Surgery. University of Michigan, Ann Arbor, MI
- . Technology Committee, Extracorporeal Life Support Organization, Ann Arbor, MI
| |
Collapse
|
4
|
Wetz AJ, Richardt EM, Schotola H, Bauer M, Bräuer A. Haptoglobin and Free Haemoglobin during Cardiac Surgery—is there a Link to Acute Kidney Injury? Anaesth Intensive Care 2017; 45:58-66. [DOI: 10.1177/0310057x1704500109] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
Acute kidney injury (AKI) is frequently observed after cardiac surgery (CS) with cardiopulmonary bypass (CPB). Multiple mechanisms underlie this phenomenon, including CPB-dependent haemolysis. Haemoglobin is released during haemolysis, and free haemoglobin (frHb) causes tubular cell injury after exceeding the binding capacity of haptoglobin (Hp). The objective of this study was to investigate the influence of perioperative changes in frHb and Hp levels on the incidence of CS-associated (CSA) AKI. After receiving local ethics committee approval and obtaining informed consent from our patients, we analysed the data pertaining to 154 patients undergoing CPB surgery. We recorded frHb and Hp concentrations pre-, intra- and postoperatively and defined AKI using the Kidney Disease Improving Global Outcomes (KDIGO) classification. We observed that frHb levels increased significantly during surgery and then decreased at ten hours thereafter and that Hp levels decreased during surgery and remained at low levels until the first postoperative day. We noted a moderate negative correlation between frHb and Hp levels. AKI was identified in 45.5% of patients; however, there was no significant difference in frHb or Hp levels between patients with and without AKI. We did not observe a relationship between frHb or Hp levels and CSA AKI and thus could not confirm the hypothesis that patients with higher baseline Hp concentrations experience a lower incidence of AKI than patients with lower baseline Hp concentrations.
Collapse
Affiliation(s)
- A. J. Wetz
- Anaesthetist, Department of Anaesthesiology, University of Goettingen, Goettingen, Germany
| | - E. M. Richardt
- Doctoral student, Department of Anaesthesiology, University of Goettingen, Goettingen, Germany
| | - H. Schotola
- Anaesthetist, Department of Anaesthesiology, University of Goettingen, Goettingen, Germany
| | - M. Bauer
- Anaesthetist, Professor, Department of Anaesthesiology, University of Goettingen, Goettingen, Germany
| | - A. Bräuer
- Anaesthetist, Professor, Department of Anaesthesiology, University of Goettingen, Goettingen, Germany
| |
Collapse
|
5
|
|
6
|
Ventetuolo CE, Muratore CS. Extracorporeal life support in critically ill adults. Am J Respir Crit Care Med 2014; 190:497-508. [PMID: 25046529 PMCID: PMC4214087 DOI: 10.1164/rccm.201404-0736ci] [Citation(s) in RCA: 89] [Impact Index Per Article: 8.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2014] [Accepted: 07/13/2014] [Indexed: 12/18/2022] Open
Abstract
Extracorporeal life support (ECLS) has become increasingly popular as a salvage strategy for critically ill adults. Major advances in technology and the severe acute respiratory distress syndrome that characterized the 2009 influenza A(H1N1) pandemic have stimulated renewed interest in the use of venovenous extracorporeal membrane oxygenation (ECMO) and extracorporeal carbon dioxide removal to support the respiratory system. Theoretical advantages of ECLS for respiratory failure include the ability to rest the lungs by avoiding injurious mechanical ventilator settings and the potential to facilitate early mobilization, which may be advantageous for bridging to recovery or to lung transplantation. The use of venoarterial ECMO has been expanded and applied to critically ill adults with hemodynamic compromise from a variety of etiologies, beyond postcardiotomy failure. Although technology and general care of the ECLS patient have evolved, ECLS is not without potentially serious complications and remains unproven as a treatment modality. The therapy is now being tested in clinical trials, although numerous questions remain about the application of ECLS and its impact on outcomes in critically ill adults.
Collapse
Affiliation(s)
- Corey E. Ventetuolo
- Division of Pulmonary, Critical Care, and Sleep, Rhode Island Hospital, Departments of Medicine and Health Services, Policy, and Practice, and
| | - Christopher S. Muratore
- Division of Pediatric Surgery, Hasbro Children’s Hospital, Department of Surgery, Alpert Medical School of Brown University, Providence, Rhode Island
| |
Collapse
|
7
|
Durandy Y, Wang S, Ündar A. An Original Versatile Nonocclusive Pressure-Regulated Blood Roller Pump for Extracorporeal Perfusion. Artif Organs 2013; 38:469-73. [DOI: 10.1111/aor.12192] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Yves Durandy
- Intensive Care Department; Pediatric Cardiac Surgery CCML; Le Plessis-Robinson France
| | - Shigang Wang
- Penn State Hershey Pediatric Cardiovascular Research Center; Departments of Pediatrics, Surgery and Bioengineering; Penn State Milton S. Hershey Medical Center; Penn State Hershey College of Medicine; Penn State Hershey Children's Hospital; Hershey PA USA
| | - Akif Ündar
- Penn State Hershey Pediatric Cardiovascular Research Center; Departments of Pediatrics, Surgery and Bioengineering; Penn State Milton S. Hershey Medical Center; Penn State Hershey College of Medicine; Penn State Hershey Children's Hospital; Hershey PA USA
| |
Collapse
|
8
|
Affiliation(s)
- Yves Durandy
- Intensive Care Unit and Perfusion Department; Pediatric Cardiac Surgery, Institut Hospitalier Jacques Cartier; Massy; France
| |
Collapse
|
9
|
Saczkowski R, Maklin M, Mesana T, Boodhwani M, Ruel M. Centrifugal Pump and Roller Pump in Adult Cardiac Surgery: A Meta-Analysis of Randomized Controlled Trials. Artif Organs 2012; 36:668-76. [DOI: 10.1111/j.1525-1594.2012.01497.x] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
10
|
Giridharan GA, Koenig SC, Kennington J, Sobieski MA, Chen J, Frankel SH, Rodefeld MD. Performance evaluation of a pediatric viscous impeller pump for Fontan cavopulmonary assist. J Thorac Cardiovasc Surg 2012; 145:249-57. [PMID: 22421403 DOI: 10.1016/j.jtcvs.2012.01.082] [Citation(s) in RCA: 55] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/08/2011] [Revised: 11/02/2011] [Accepted: 01/12/2012] [Indexed: 11/24/2022]
Abstract
OBJECTIVE The anatomic and physiologic constraints for pediatric cavopulmonary assist differ markedly from adult Fontan circulations owing to smaller vessel sizes and risk of elevated pulmonary resistance. In this study, hemodynamic and hemolysis performance of a catheter-based viscous impeller pump (VIP) to power the Fontan circulation is assessed at a pediatric scale (∼15 kg) and performance range (0-30 mm Hg). METHODS Computer simulation and mock circulation studies were conducted to assess the hydraulic performance, acute hemodynamic response to different levels VIP support, and the potential for vena caval collapse. Computational fluid dynamics simulations were used to estimate VIP hydraulic performance, shear rates, and potential for hemolysis. Hemolysis was quantified in a mock loop with fresh bovine blood. RESULTS A VIP augmented 4-way total cavopulmonary connection flow at pediatric scales and restored systemic pressures and flows to biventricular values, without causing flow obstruction or suction. VIP generated flows up to 4.1 L/min and pressure heads of up to 38 mm Hg at 11,000 rpm. Maximal shear rate was 160 Pa, predicting low hemolysis risk. Observed hemolysis was low with plasma free hemoglobin of 11.4 mg · dL(-1) · h(-1). CONCLUSIONS A VIP will augment Fontan cavopulmonary flow in the proper pressure and flow ranges, with low hemolysis risk under more stringent pediatric scale and physiology compared with adult scale. This technology may be developed to simultaneously reduce systemic venous pressure and improve cardiac output after stage 2 or 3 Fontan repair. It may serve to compress surgical staging, lessening the pathophysiologic burden of repair.
Collapse
Affiliation(s)
- Guruprasad A Giridharan
- Department of Bioengineering, Cardiovascular Innovation Institute, University of Louisville, Louisville, KY, USA
| | | | | | | | | | | | | |
Collapse
|
11
|
Design Optimization and Performance Studies of an Adult Scale Viscous Impeller Pump for Powered Fontan in an Idealized Total Cavopulmonary Connection. Cardiovasc Eng Technol 2011. [DOI: 10.1007/s13239-011-0058-2] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
12
|
Riley JB, Scott PD, Schears GJ. Update on safety equipment for extracorporeal life support (ECLS) circuits. Semin Cardiothorac Vasc Anesth 2009; 13:138-45. [PMID: 19720681 DOI: 10.1177/1089253209347895] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Though much has been surveyed and written about the equipment aspects of extracorporeal life support (ECLS) in the past 10 years, there is value in reviewing the use and nonuse of multiple safety devices and techniques. Minimally equipped ECLS circuits for adult and pediatric bridge to decision during cardiac and respiratory failure are rapidly gaining popularity to maintain simplicity and portability. ECLS circuits employed for long-term therapy are outfitted differently and should include more safety devices. The purpose of this review is to compare and contrast the spectrum of minimally equipped ECLS circuits to circuits with maximum flexibility and safety device protection. Due to the lack of high-level, well-controlled scientific studies regarding ECLS equipment and safety devices, this study reviews the basis for how we use ECLS circuits and devices in our institution to provide safe patient support.
Collapse
Affiliation(s)
- Jeffrey B Riley
- Perfusion Services Work Group, Cardiovascular Surgery Department, Mayo Clinic, Rochester, Minnesota 55905, USA.
| | | | | |
Collapse
|
13
|
Murphy GS, Hessel EA, Groom RC. Optimal Perfusion During Cardiopulmonary Bypass: An Evidence-Based Approach. Anesth Analg 2009; 108:1394-417. [DOI: 10.1213/ane.0b013e3181875e2e] [Citation(s) in RCA: 233] [Impact Index Per Article: 15.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
14
|
Moon YS, Ohtsubo S, Gomez MR, Moon JK, Nose Y. Comparison of Centrifugal and Roller Pump Hemolysis Rates at Low Flow. Artif Organs 2008; 20:579-581. [PMID: 28868720 DOI: 10.1111/j.1525-1594.1996.tb04485.x] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
We compared in vitro rates of hemolysis for a recently developed centrifugal pump with a conventional roller pump (10-10-00; Stöckert, Munich, Germany). Flow rates of 0.3 L/min and 1 L/min and a pressure of 200 mm Hg were chosen to simulate conditions during neonatal extracorporeal membrane oxygenation (ECMO). There was no significant difference in hemolysis rates between centrifugal and roller pumps (p = 0.57) nor between high and low flow (p = 0.86). The centrifugal pump caused no more blood trauma than the roller pump at the low-flow/high-pressure conditions required for neonatal ECMO. The Nikkiso pump is superior to roller pumps in size and priming volume (25 ml) and may permit development of a smaller and simpler ECMO system.
Collapse
Affiliation(s)
- Yuko S Moon
- Departments of Pediatrics, Baylor College of Medicine, Houston, Texas, U.S.ASurgery, Baylor College of Medicine, Houston, Texas, U.S.A
| | - Satoshi Ohtsubo
- Departments of Pediatrics, Baylor College of Medicine, Houston, Texas, U.S.ASurgery, Baylor College of Medicine, Houston, Texas, U.S.A
| | - Michael R Gomez
- Departments of Pediatrics, Baylor College of Medicine, Houston, Texas, U.S.ASurgery, Baylor College of Medicine, Houston, Texas, U.S.A
| | - Jon K Moon
- Departments of Pediatrics, Baylor College of Medicine, Houston, Texas, U.S.ASurgery, Baylor College of Medicine, Houston, Texas, U.S.A
| | - Yukihiko Nose
- Departments of Pediatrics, Baylor College of Medicine, Houston, Texas, U.S.ASurgery, Baylor College of Medicine, Houston, Texas, U.S.A
| |
Collapse
|
15
|
Ohtsubo S, Tayama E, Short D, Noon GP, Nose Y. Clinical Comparative Study of Cardiopulmonary Bypass with Nikkiso and BioMedicus Centrifugal Pumps. Artif Organs 2008; 20:715-720. [PMID: 28868702 DOI: 10.1111/j.1525-1594.1996.tb04510.x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
The Nikkiso centrifugal pump was evaluated in elective adult open heard surgery in comparison with the BioMedicus pump. Ten patients using the Nikkiso pump (Group N), and 10 patients using the BioMedicus pump (Group B) were examined for (or to determine) hemato-biologic parameters and patient outcome data as well as pump controllability. During cardiopulmonary bypass (CPB), both pumps maintained systemic perfusion satisfactorily without any mechanical adverse event. Rotation speed of the Nikkiso centrifugal pump (3,580 ± 100 rpm) was significantly higher than that of the BioMedicus pump (3,170 ± 100 rpm; p < 0.05) whereas changes in free plasma hemoglobin, platelet count, blood urea nitrogen, and creatinine levels showed no significant differences between the two groups. Urine output in Group N for 30 min after the initiation of CPB (7.10 ± 1.50 ml/kg/h) was significantly higher than that in Group B (3.23 ± 0.46 ml/kg/h; p < 0.05). Patient outcome data were similar in both groups, such as duration of intensive care unit stay, hospital stay, postoperative intubation time, amount of postoperative bleeding, and amount of blood transfused. These equivalent results with the BioMedicus pump suggested that the Nikkiso pump can be used in open heart surgery as a reliable and atraumatic CPB pump.
Collapse
Affiliation(s)
- Satoshi Ohtsubo
- Department of Surgery, Baylor College of Medicine, Houston, Texas, U.S.A
| | - Eiki Tayama
- Department of Surgery, Baylor College of Medicine, Houston, Texas, U.S.A
| | - David Short
- Department of Surgery, Baylor College of Medicine, Houston, Texas, U.S.A
| | - George P Noon
- Department of Surgery, Baylor College of Medicine, Houston, Texas, U.S.A
| | - Yukihiko Nose
- Department of Surgery, Baylor College of Medicine, Houston, Texas, U.S.A
| |
Collapse
|
16
|
Hart RM, Filipenco VG, Kung RT. A Magnetically Suspended and Hydrostatically Stabilized Centrifugal Blood Pump. Artif Organs 2008; 20:591-596. [DOI: 10.1111/j.1525-1594.1996.tb04487.x] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
17
|
Andrade A, Biscegli J, Dinkhuysen J, Sousa JE, Ohashi Y, Hemmings S, Glueck J, Kawahito K, Nosé Y. Characteristics of a Blood Pump Combining the Centrifugal and Axial Pumping Principles: The Spiral Pump. Artif Organs 2008; 20:605-612. [PMID: 28868707 DOI: 10.1111/j.1525-1594.1996.tb04489.x] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Two well-known centrifugal and axial pumping principles are used simultaneously in a new blood pump design. Inside the pump housing is a spiral impeller, a conically shaped structure with threads on the surface. The worm gears provide an axial motion of the blood column through the threads of the central cone. The rotational motion of the conical shape generates the centrifugal pumping effect and improves the efficiency of the pump without increasing hemolysis. The hydrodynamic performance of the pump was examined with a 40% glycerin-water solution at several rotation speeds. The gap between the housing and the top of the thread is a very important factor: when the gap increases, the hydrodynamic performance decreases. To determine the optimum gap, several in vitro hemolysis tests were performed with different gaps using bovine blood in a closed circuit loop under two conditions. The first simulated condition was a left ventricular assist device (LVAD) with a flow rate of 5 L/min against a pressure head of 100 mm Hg, and the second was a cardiopulmonary bypass (CPB) simulation with a flow rate of 5 L/min against 350 mm Hg of pressure. The best hemolysis results were seen at a gap of 1.5 mm with the normalized index of hemolysis (NIH) of 0.0063 ± 0.0020 g/100 L and 0.0251 ± 0.0124 g/100 L (mean ± SD; n = 4) for LVAD and CPB conditions, respectively.
Collapse
Affiliation(s)
- Aron Andrade
- Institute Dante Pazzanese of Cardiology, Department of Bioengineering, Sao Paulo, BrazilBaylor College of Medicine, Department of Surgery, Houston, Texas, U.S.A
| | - José Biscegli
- Institute Dante Pazzanese of Cardiology, Department of Bioengineering, Sao Paulo, BrazilBaylor College of Medicine, Department of Surgery, Houston, Texas, U.S.A
| | - Jarbas Dinkhuysen
- Institute Dante Pazzanese of Cardiology, Department of Bioengineering, Sao Paulo, BrazilBaylor College of Medicine, Department of Surgery, Houston, Texas, U.S.A
| | - José Eduardo Sousa
- Institute Dante Pazzanese of Cardiology, Department of Bioengineering, Sao Paulo, BrazilBaylor College of Medicine, Department of Surgery, Houston, Texas, U.S.A
| | - Yukio Ohashi
- Institute Dante Pazzanese of Cardiology, Department of Bioengineering, Sao Paulo, BrazilBaylor College of Medicine, Department of Surgery, Houston, Texas, U.S.A
| | - Sarah Hemmings
- Institute Dante Pazzanese of Cardiology, Department of Bioengineering, Sao Paulo, BrazilBaylor College of Medicine, Department of Surgery, Houston, Texas, U.S.A
| | - Julie Glueck
- Institute Dante Pazzanese of Cardiology, Department of Bioengineering, Sao Paulo, BrazilBaylor College of Medicine, Department of Surgery, Houston, Texas, U.S.A
| | - Koji Kawahito
- Institute Dante Pazzanese of Cardiology, Department of Bioengineering, Sao Paulo, BrazilBaylor College of Medicine, Department of Surgery, Houston, Texas, U.S.A
| | - Yukihiko Nosé
- Institute Dante Pazzanese of Cardiology, Department of Bioengineering, Sao Paulo, BrazilBaylor College of Medicine, Department of Surgery, Houston, Texas, U.S.A
| |
Collapse
|
18
|
Abstract
Conventional treatment of respiratory failure involves positive pressure ventilation with high concentrations of inspired oxygen. If adequate gas exchange still cannot be achieved extracorporeal membrane oxygenation (ECMO) may be an option. The general indication for ECMO for respiratory insufficiency is a reversible pulmonary disease, which cannot be managed by conventional means. ECMO is a modified heart-lung machine. Blood is withdrawn from a central vein in the patient and pumped through an artificial oxygenator back to the patient, either to a central artery (veno-arterial ECMO) or to a central vein (veno-venous ECMO). Total gas exchange can be achieved through the extracorporeal system, and the lungs do not have to be subjected to high-pressure ventilation. To date over 21,500 neonates have been treated with ECMO with an overall survival to hospital discharge of 76%. Meconium aspiration syndrome carries the highest survival (94%), whereas congenital diaphragmatic hernia on ECMO only has a survival of 52%. A total of 3500 pediatric patients (30 days to 18 years) have been treated with ECMO with a survival of 56%. Aspiration and viral pneumonia are the pediatric diagnoses with the highest survival rates. Randomized controlled studies have shown a significant advantage of ECMO with regard to survival in neonates. In the pediatric age group, nonrandomized studies have shown lower mortality in ECMO-treated patients.
Collapse
Affiliation(s)
- Björn Frenckner
- Department of Pediatric Surgery, Astrid Lindgren Children's Hospital, Karolinska Institutet, Stockholm, Sweden.
| | | |
Collapse
|
19
|
|
20
|
Lawson DS, Ing R, Cheifetz IM, Walczak R, Craig D, Schulman S, Kern F, Shearer IR, Lodge A, Jaggers J. Hemolytic characteristics of three commercially available centrifugal blood pumps. Pediatr Crit Care Med 2005; 6:573-7. [PMID: 16148820 DOI: 10.1097/01.pcc.0000163282.63992.13] [Citation(s) in RCA: 81] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
OBJECTIVE As compared with traditional extracorporeal roller-occlusion blood pumps, nonocclusive centrifugal pumps offer the benefits of requiring a smaller circuit surface area and, thus, a smaller prime volume. However, centrifugal blood pumps have been reported to generate unacceptable levels of hemolysis. We hypothesize that the newer generation centrifugal pumps have an incidence of hemolysis similar to the traditional roller head pumps and, thus, could be used for extracorporeal membrane oxygenation circuits. DESIGN Randomized, prospective, bench study. SETTING University research laboratory. INTERVENTIONS Three centrifugal blood pumps (Cobe Revolution, Jostra Rotaflow, and Medtronic BioMedicus) were compared with a roller occlusion blood pump (Cobe Century). Hemolysis generation was examined during 6 hrs of continuous use. Two test runs per group were randomly performed on three consecutive days for a total of six test runs for each of the four pumps (n = 24). MEASUREMENTS AND MAIN RESULTS Plasma free hemoglobin values were determined using a Spectra MaxPlus spectrophotometer. A normalized index of hemolysis was calculated to compare the individual trials. The Cobe Revolution and the Jostra Rotaflow compared favorably with the Cobe Century roller occlusion blood pump in the amount of hemolysis produced. CONCLUSIONS These data are encouraging for the development of a low-prime, mobile neonatal extracorporeal membrane oxygenation circuit using centrifugal pump technology.
Collapse
Affiliation(s)
- D Scott Lawson
- Department of Perfusion Services, Duke University Health System, Durham, NC, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Burda G, Trittenwein H, Carole H, Trittenwein G. Testing of extracorporeal membrane oxygenation circuit related hemolysis using long-term stored packed red cells and fresh frozen plasma. Artif Organs 2004; 28:496-9. [PMID: 15113345 DOI: 10.1111/j.1525-1594.2004.07154.x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
BACKGROUND The resistance of blood used in these studies to hemolysis differs markedly from that used in neonatal extracorporeal circulation under clinical circumstances. In this study, the possibility of using expired packed red cells to determine hemolysis caused by mechanical and/or environmental factors was investigated. METHODS Packed red blood cells stored for 42 days were mixed with fresh frozen plasma and the resultant mixture was divided into three groups, two study groups and a control. For the study groups, two different centrifugal pump heads (Medtronic BP 50 and Jostra RF 32) were used in an extracorporeal membrane oxygenation (ECMO) circuit. Free hemoglobin, lactate dehydrogenase, lactic acid, pH, potassium, and glucose were investigated at various time intervals. RESULTS Hemolysis did not differ between the groups. Free hemoglobin increased in all groups after 12 h. Lactic acid increased linearly in all groups up to 12 h. Glucose and pH decreased steadily in all groups. Hemolysis created during mock ECMO did not differ between the circuits using the two different pump heads noted. CONCLUSION Human donor blood stored up to its expiration date is a feasible medium for mock circulation tests of up to 12 h duration under the circumstances described.
Collapse
Affiliation(s)
- Gudrun Burda
- Department of Neonatology and Pediatric Intensive Care, University Children's Hospital, Vienna, Austria.
| | | | | | | |
Collapse
|
22
|
Cook DJ. Con: low-flow cardiopulmonary bypass is not the preferred technique for patients undergoing cardiac surgical procedures. J Cardiothorac Vasc Anesth 2001; 15:652-4. [PMID: 11688011 DOI: 10.1053/jcan.2001.26552] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- D J Cook
- Department of Anesthesiology, Mayo Clinic, Rochester, MN 55905, USA.
| |
Collapse
|
23
|
Neelakanta G, Colquhoun S, Csete M, Koroleff D, Mahajan A, Busuttil RW. Efficacy and safety of heat exchanger added to venovenous bypass circuit during orthotopic liver transplantation. LIVER TRANSPLANTATION AND SURGERY : OFFICIAL PUBLICATION OF THE AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES AND THE INTERNATIONAL LIVER TRANSPLANTATION SOCIETY 1998; 4:506-9. [PMID: 9791162 DOI: 10.1002/lt.500040610] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Hypothermia during orthotopic liver transplantation (OLT) is common despite measures to prevent this complication. We retrospectively analyzed two groups of patients; those managed with (n = 113) or without (n = 109) a heat exchanger (HE) incorporated in the venovenous bypass (VVB) circuit to test the hypothesis that normothermia before liver reperfusion minimizes hypotension during reperfusion and decreases neohepatic transfusion requirements. Use of the HE resulted in significantly warmer patients during reperfusion and at the end of surgery (P < .001). An increase in neohepatic transfusion requirement was observed in patients with HE use: packed red blood cells, 4 +/- 4 versus 3 +/- 3 units; fresh-frozen plasma, 5 +/- 5 versus 4 +/- 4 units; platelets, 8 +/- 8 versus 6 +/- 7 units; and cryoprecipitate, 5 +/- 7 versus 3 +/- 5 units. There was no difference between the two groups in the untoward hemodynamic events during reperfusion of the liver (P = .31). We conclude that during OLT, the use of an HE in a nonheparinized VVB circuit helps maintain normothermia. Our limited experience suggests that its use is safe but does not improve hemodynamic stability during reperfusion or decrease blood loss during the neohepatic period.
Collapse
Affiliation(s)
- G Neelakanta
- Departments of Anesthesiology, Dumont-University of California/Los Angeles Liver Transplant Center, Los Angeles, CA, USA
| | | | | | | | | | | |
Collapse
|
24
|
Mongero LB, Beck JR, Orr TW, Kroslowitz RM, Lee-Sensiba K, Oz MC. Clinical evaluation of setting pump occlusion by the dynamic method: effect on flow. Perfusion 1998; 13:360-8. [PMID: 9778722 DOI: 10.1177/026765919801300513] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Pump manufacturers recommend setting roller pump occlusion such that the level of a 100 cm column of crystalloid drops 2.5 cm/min (Sarns, 8000 Modular Perfusion System, operator's manual, roller pump software version 2.3L. May 1993; 2.1-2.14). Though this almost occlusive setting ensures accurate pump flow, it has been shown to cause more hemolysis than nonocclusive pumps (Noon GP, Kane LE, Feldman L et al. Reduction of blood trauma in roller pumps for long-term perfusion. World J Surg 1985; 9: 65-71). We conducted a clinical study (n = 19) to compare the standard occlusion method with the dynamic method and to determine the accuracy of flow for the nonocclusive pump. Standard occlusion was set by clamping the pump tubing distal to the arterial line filter and timing the drop in pump outlet pressure as indicated by a pressure transducer connected to the filter. The occlusion setting, expressed in mmHg/s, was recorded for each roller at two specific points along the raceway. The pump was then set nonocclusively with the dynamic method using the Better Header (BH) (Circulatory Technology, Oyster Bay, NY, USA). Readings of the change in pressure in the same two selected points on the raceway were taken. The latter was repeated after discontinuation of bypass. Flow was recorded throughout the procedure from both roller pump output display and a flow meter (Model #109 Transonic, Ithaca, NY, USA). The average drop in pump outlet pressure for the standard method was 1.3 +/- 4.0 (range 0-18 mmHg/s), and for the dynamic method was 38 +/- 28 (range 1.2-89 mmHg/s). Off bypass, the average reading was 44 +/- 38 (range 2.0-103 mmHg/s). Regression analysis indicates that patient flow, when corrected for retrograde flow by the dynamic method, equals 1.003 x revolutions per minute + 40 ml/min (r2 = 0.964). The average error between indicated pump flow, corrected for retrograde flow, was -1% (range from -6.7 to 6.6%). We conclude that the BH allows nonocclusive setting (30 times less than our standard method) without sacrificing pump flow accuracy.
Collapse
Affiliation(s)
- L B Mongero
- Columbia-Presbyterian Medical Center, Milstein Hospital, New York, NY 10032, USA
| | | | | | | | | | | |
Collapse
|
25
|
Klein M, Dauben HP, Schulte HD, Gams E. Centrifugal pumping during routine open heart surgery improves clinical outcome. Artif Organs 1998; 22:326-36. [PMID: 9555964 DOI: 10.1046/j.1525-1594.1998.06051.x] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
Carrying out a 1,000 patient prospective, randomized study comparing a roller pump and the BioMedicus centrifugal pump (CP), hematological parameters, blood loss, renal function, postoperative complications, and lethality data were evaluated. Using a validated preoperative risk stratification method (Cardiac RiskMaster), patients were divided into different risk categories for statistical analysis. This study verified an improved outcome with the use of a CP in routine cardiac surgery, demonstrated by blood handling, blood loss, renal function, and nephrological complication data. There was also a significant reduction in neurological complications. There was no significant difference in postoperative lethality, but high risk patients demonstrated outcomes comparable to those being defined for medium risk patients. Routine cardiac surgical patients as well as multimorbid patients benefit from the use of a CP. Preoperative risk stratification is a valid tool to demonstrate how the employment of new technologies can provide for an improved outcome without increasing overall costs at the same time.
Collapse
Affiliation(s)
- M Klein
- Department of Cardiothoracic Surgery, Heinrich-Heine University Hospital, Düsseldorf, Germany
| | | | | | | |
Collapse
|
26
|
Ashraf SS, Tian Y, Cowan D, Shaikh R, Parsloe M, Martin P, Watterson KG. Proinflammatory cytokine release during pediatric cardiopulmonary bypass: influence of centrifugal and roller pumps. J Cardiothorac Vasc Anesth 1997; 11:718-22. [PMID: 9327312 DOI: 10.1016/s1053-0770(97)90164-6] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
OBJECTIVE It has been proposed that nonocclusive centrifugal pumps may elicit less blood cell trauma and hence a reduced inflammatory response than standard roller pumps. However, there have been no reports describing the impact of such pumps on proinflammatory cytokine release in pediatric cohorts. DESIGN A prospective randomized study was undertaken. SETTING A regional cardiothoracic center of a university hospital. PARTICIPANTS Thirty-four pediatric patients undergoing cardiopulmonary bypass (CPB) for the correction of complex congenital heart defects were recruited. INTERVENTIONS Either standard twin roller (n = 17), or centrifugal vortex (Biopump, Medtronic Biomedicus Inc, MN) (n = 17) blood pumping. MEASUREMENTS AND MAIN RESULTS Venous blood was drawn (1) on induction of anesthesia, (2) 5 minutes on bypass, (3) end of CPB, (4) 30 minutes post-protamine, (5) 2 hours and (6) 24 hours postoperation. Neutrophil count, level of plasma leukocyte elastase, terminal complement complex (C5b-9); interleukin-6 (IL-6) and interleukin-8 (IL-8) were increased during and after CPB compared with the postinduction baseline. C5b-9 levels in both groups peaked at the end of CPB before returning to baseline at 24 hours: (median [range]), 564 (16 to 1,136) ng/mL in centrifugal group versus 508 (0 to 1,128) ng/mL in the roller group. IL-6 in both groups reached its peak level at 2 hours postprotamine (208 [98 to 411] pg/mL in centrifugal versus 205 [60-327] pg/mL in the roller group), before coming back to baseline at 24 hours. Plasma leukocyte elastase and IL-8 reached their maximum level 15 minutes after protamine administration: 215 (64 to 375) pg/mL in centrifugal versus 235 (87 to 410) pg/mL in roller group; and 700 (90 to 5,925) ng/mL versus 362 (120 to 3,400) ng/mL, respectively. CONCLUSIONS The current study confirms the proinflammatory nature of pediatric CPB surgery, but failed to show a significant advantage of centrifugal pumping over roller perfusion in terms of the inflammatory response.
Collapse
Affiliation(s)
- S S Ashraf
- Department of Cardiothoracic Surgery, Leeds General Infirmatory, UK
| | | | | | | | | | | | | |
Collapse
|
27
|
Kawahito K, Mohara J, Misawa Y, Fuse K. Platelet damage caused by the centrifugal pump: in vitro evaluation by measuring the release of alpha-granule packing proteins. Artif Organs 1997; 21:1105-9. [PMID: 9335369 DOI: 10.1111/j.1525-1594.1997.tb00450.x] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Platelets are more vulnerable to damage than erythrocytes because platelets are easily activated by contact with extracorporeal circuits and by exposure to shear forces. However, the degree of platelet damage caused by centrifugal pumps is unclear. To evaluate platelet damage in different pumping conditions, the rates of increase for specific proteins in platelet alpha-granules, beta-thromboglobulin (beta-TG), and platelet factor 4 (PF-4) were measured in both in vitro simulated left ventricular assist device (LVAD) and cardiopulmonary bypass (CPB) conditions and compared with the erythrocyte trauma. A flow of 5.0 L/min with deltaP of 100 mm Hg for LVAD (low pressure head condition) and a flow of 5.0 L/min with deltaP of 350 mm Hg for CPB (high pressure head condition) were investigated. Each condition was tested 4 times for 3 h in a mock circuit with a Capiox (Terumo, Tokyo, Japan) centrifugal pump using fresh human blood. Blood was sampled at 1 h intervals, measuring plasma free hemoglobin (fHb), beta-TG, and PF-4. To evaluate the degree of damage, the rates of increase of fHb, beta-TG, and PF-4 were calculated for each condition as deltafHb/deltaN, deltabeta-TG/deltaN, and deltaPF-4/deltaN where deltafHb is the increase in plasma free hemoglobin, deltabeta-TG is the increase in beta-TG, deltaPF-4 is the increase in PF-4, and deltaN is the increase in the passing number. The passing number is defined in the following equation: N = Qt/V where t is the time, V is the priming volume, and Q is the flow rate. There was no significant difference between the 2 conditions (low pressure head condition versus high pressure head condition) in the rate of increase of fHb (0.0035+/-0.0004 vs. 0.0034+/-0.0010 g/100 L, NS). Contrary to this, the rates of increase for specific proteins in platelet alpha-granules in the high pressure head condition demonstrated a significantly higher rate of increase than in the low pressure head condition. The mean rate of increase for beta-TG in the low pressure head condition was 0.22+/-0.03 ng/ml and in the high pressure head condition was 0.51+/-0.05 ng/ml (p < 0.05). The rate of increase for PF-4 in the low pressure head condition was 0.11+/-0.02 ng/ml and in the high pressure head condition was 0.30+/-0.06 ng/ml (p < 0.05). These results suggest that measurements of beta-TG and PF-4 may be more sensitive parameters than hemolysis for evaluating blood cell trauma and that platelets are more vulnerable to mechanical damage by a centrifugal pump than erythrocytes.
Collapse
Affiliation(s)
- K Kawahito
- Jichi Medical School, Department of Cardiovascular Surgery, Tochigi, Japan
| | | | | | | |
Collapse
|
28
|
Abstract
Different types of centrifugal pumps cause different amounts of hemolysis based on shear stress and blood exposure time. However, the hemolytic characteristics of centrifugal pumps in each clinical condition are not always clear. We compared the hemolytic characteristics of one cone-type centrifugal pump (Medtronic BioMedicus BP-80) and 2 impeller-type centrifugal pumps (Nikkiso HMS-12 and Terumo Capiox) under experimental conditions simulating their use in cardiopulmonary bypass (CPB), extracorporeal membrane oxygenation (ECMO), and percutaneous cardiopulmonary support (PCPS) as well as their use as left ventricular assist devices (LVADs). The normalized indexes of hemolysis (NIHs; grams free plasma hemoglobin per 100 L blood pumped) during use as LVADs were not significantly different among the 3 pumps. The BP-80 pump produced almost 3-fold more hemolysis than the HMS-12 and Capiox pumps during CPB, 3- to 4-fold more hemolysis during ECMO, and 5.5-fold more hemolysis during PCPS. The 2 impeller-type centrifugal pumps will therefore cause less hemolysis under high flow, high pressure difference (as in CPB) and low flow, high pressure difference (as in ECMO and PCPS) conditions than the cone-type pump.
Collapse
Affiliation(s)
- K Kawahito
- Department of Surgery, Baylor College of Medicine, Houston, Texas 77030, USA
| | | |
Collapse
|
29
|
Gazmuri RJ, Becker J. Cardiac resuscitation. The search for hemodynamically more effective methods. Chest 1997; 111:712-23. [PMID: 9118713 DOI: 10.1378/chest.111.3.712] [Citation(s) in RCA: 25] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023] Open
Affiliation(s)
- R J Gazmuri
- Medical Service, North Chicago VA Medical Center, IL 60064, USA
| | | |
Collapse
|
30
|
Takami Y, Makinouchi K, Nakazawa T, Benkowski R, Glueck J, Ohara Y, Nosé Y. Hemolytic characteristics of a pivot bearing supported Gyro centrifugal pump (C1E3) simulating various clinical applications. Artif Organs 1996; 20:1042-9. [PMID: 8864026 DOI: 10.1111/j.1525-1594.1996.tb04592.x] [Citation(s) in RCA: 42] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Centrifugal blood pumps are playing a key role in circulatory mechanical assist systems including cardiopulmonary bypass (CPB), right and left ventricular assist devices (RVAD and LVAD), percutaneous cardiopulmonary support (PCPS), and extracorporeal membrane oxygenation (ECMO). Each of these circulatory assist systems requires specific flow and pressure conditions. In vitro hemolysis tests were performed using five compact mock loops with flow and pressure set equivalent to clinical conditions. These studies determined the hemolytic characteristics and clinical applicability of the pivot bearing-supported Gyro centrifugal pump with an eccentric port (C1E3) compared with the Bio-Medicus pump (BP-80). Normalized index of hemolysis (NIH) values of the C1E3 were less than those of the BP-80 under all conditions; in particular, they were significantly less in the CPB, LVAD, and RVAD conditions. In addition, linear correlation was observed between NIH values, rotational pump speed (RPM), total pressure head (delta P), and flow rate (Q) with both the C1E3 and BP-80: NIH = a(RPM/Q) + b, NIH = c(delta P/Q) + d. However, the slopes (a and c) of these equations were smaller with the C1E3 than those with the BP-80, which suggests that the C1E3 has decreased hemolytic characteristics when increasing the RPM and delta P. In other words, the increase of RPM and delta P results in less shear stress with the C1E3 than with the BP-80. One cause of these decreased hemolytic characteristics of the C1E3 is thought to be less pump power loss against an increase of RPM and delta P than with the BP-80. Furthermore, the average exposure time is shorter with the C1E3 than with the BP-80 because the priming volume of the C1E3 (30 ml) is smaller than that of the BP-80 (80 ml). From the point of both shear stress and exposure time, the C1E3 has less hemolytic features than the BP-80.
Collapse
Affiliation(s)
- Y Takami
- Department of Surgery, Baylor College of Medicine, Houston, Texas 77030, USA
| | | | | | | | | | | | | |
Collapse
|
31
|
Nakazawa T, Makinouchi K, Takami Y, Glueck J, Takatani S, Nosé Y. Modification of a pivot bearing system on a compact centrifugal pump. Artif Organs 1996; 20:258-63. [PMID: 8694697 DOI: 10.1111/j.1525-1594.1996.tb04435.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
The pivot bearing centrifugal blood pump was developed as a long-term centrifugal ventricular assist device (VAD) as well as a cardiopulmonary bypass pump. This pivot bearing supported centrifugal pump with an eccentric port (CIE) incorporates a seal-less design with a blood stagnation-free structure. This pump can provide flows of 12 L/min against 650 mm Hg total pressure head at 3,600 rpm, and in a CPB condition 5 L/min against 350 mm Hg total pressure head at 2,600 rpm. Very recently, the pivot bearing system was modified to obtain a stable and smooth spinning movement. The material of the female pivot was changed from ceramic to polyethylene. Three kinds of bearings were tested simultaneously with bovine blood in two types of in vitro circuits to determine the blood damage from the bearings. Pressure differences across the pump (total head pressure, delta P) of 140 mm Hg (n = 12) and 330 mm Hg (n = 12) were examined. The normalized index of hemolysis (NIH) was slightly higher in a ball bearing (BB) pump than in a polyethylene bearing (PB) pump and statistically higher than the BioMedicus Pump (BP-80) on delta P of 140 mm Hg. When the delta P was at 330 mm Hg, a comparison between the three types of pumps revealed no difference in NIH. In addition, the primary vane of the impeller was redesigned to obtain an atraumatic structure. In the second study (n = 14), there was no difference in the NIH between BP-80 and the current model when the delta P was 300 mm Hg (0.019 +/- 0.002 vs. 0.027 +/- 0.006, p = 0.3) and/or when the delta P was 100 mm Hg (0.0008 +/- 0.0001 vs. 0.0014 +/- 0.0002, p = 0.07). The modified pivot bearing had an improved spinning condition and no change in hemolysis. A proper selection of pivot bearing materials is important to develop an atraumatic centrifugal pump. The modification of the bearing system and redesign of the vane enabled a compact centrifugal pump to become a reality.
Collapse
Affiliation(s)
- T Nakazawa
- Department of Surgery, Baylor College of Medicine, Houston, TX 77030, USA
| | | | | | | | | | | |
Collapse
|
32
|
Abstract
At present, hemolysis is one of the most important characteristics used to evaluate rotary blood pumps. However, the conditions of testing procedures in various research centers differ considerably. We proposed to conduct the experiments under conditions similar to those from clinical applications of arterial pumps in extracorporeal perfusion. Proceeding from these considerations, the following parameters of Hemolysis (H) testing were adopted: output, 6 L/min; difference of pressure, 300 mm Hg; initial hematocrit, 30 mg%; and initial hemolysis (PHbo) < 5 mg%. The channel pump IBP80 designed on the basis of the BP80 was tested using fresh human blood. The experimental results indicate that the H level due to the use of the IBP80 is 2-3 times less than H for the BP80. H dependence on the difference of pressure in the range between 200 and 300 mm Hg was noted for the BP80, which can be accounted for by the transition of the laminar conditions of flow to turbulence. According to the results of the hydrodynamic efficiency evaluation, the IBP80 is twice as efficient as the BP80.
Collapse
Affiliation(s)
- G P Itkin
- Institute of Transplantology and Artificial Organs, Moscow, Russia
| | | | | |
Collapse
|
33
|
Hager J, Koller J, Gschnitzer F, Fitz A, Klima G, Brandstaetter F. Considerations and problems in the development of the mini-spindle pump. Artif Organs 1995; 19:660-4. [PMID: 8572969 DOI: 10.1111/j.1525-1594.1995.tb02398.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
The premise for the development of the mini-spindle pump, planned as an implantable device for assisted circulation, was to transport 4 L of water/min in mock circulation with a speed of 12-15,000 rpm against an afterload of 90 mm Hg. After calculations, the resulting first prototype had a spindle rotor with 3 threads (outer diameter, 18 mm; inner diameter, 6.2 mm; length, 45 mm) in a U-shaped housing, driven by an electric motor with a cooling system. In mock circulation, this pump moved 7.8 L of water/min at 18,000 rpm. To avoid animal experiments, its influence on the blood was tested in a Maxima oxygenator. The device circulated 4.2 L of blood/min with the same speed. Because of its high traumatic hemolysis rate (> 250 mg% of free hemoglobin after 7 h of pumping), the rotor was modified, first without effect at 2.5 threads and then at 4 threads. In addition, in this third prototype, the flow direction was reversed. This prototype was more effective (4.3 L of blood/min at 12,000 rpm in the oxygenator) and the hemolysis rate, after a pumping duration of 8 h, could only be reduced to 180 mg% of free hemoglobin. As a result, a fourth prototype was developed (i.e., the U-shape of the housing was abandoned). This device functioned better than the third prototype (4.5 L of blood/min at 12,000 rpm in the oxygenator), but the blood trauma increased (220 mg% of free hemoglobin after 7 h of pumping).(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
Affiliation(s)
- J Hager
- Surgical Clinic I, University of Innsbruck, Austria
| | | | | | | | | | | |
Collapse
|
34
|
Bartlett RH. Invited commentary. Ann Thorac Surg 1994. [DOI: 10.1016/0003-4975(94)90102-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|